1

BUKU PANDUAN MAHASISWA

BLOK MEDICAL RESEARCH PROGRAM (5.2)

Disusun oleh :
Dr. dr. Lantip Rujito, M.Si. Med.
Rani Afifah Nur Hestiyani, S.Si., M.Biotech.
Anriani Puspita Karunia Ning Widhi, S.Si., M.Si.

KEMENTERIAN RIET, TEKNOLOGI DAN PENDIDIKAN TINGGI

UNIVERSITAS JENDERAL SOEDIRMAN
FAKULTAS KEDOKTERAN
JURUSAN KEDOKTERAN UMUM
2019
 2

DESKRIPSI BLOK
Blok Medical Research Program (5.2) merupakan blok kedua dalam semester lima. Pada blok
ini mahasiswa mempelajari metodologi penelitian kedokteran. Blok ini memiliki beban 4 SKS.

KARAKTERISTIK MAHASISWA
Mahasiswa yang mengikuti Blok Medical Research Program adalah mahasiswa semester lima.

KONTRIBUTOR
Kontributor Blok Medical Research Program adalah bagian:
o Komisi Ilmiah
o Bioetik
o IKM

TUJUAN UMUM
Pada akhir blok, mahasiswa diharapkan mampu :
- Menyusun sebuah proposal penelitian kedokteran
- Mengidentifikasi adanya permasalahan etik pada sebuah penelitian kedokteran
- Melakukan analisis statistik pada data hasil penelitian kedokteran
- Menyusun sebuah laporan dan artikel penelitian kedokteran
- Melakukan critical appraisal pada sebuah jurnal/berkala kedokteran

ORGANISASI PENGELOLA BLOK

1. PIC 1 : Dr. dr. Lantip Rujito, M.Si, Med
2. PIC 2 : Rani Afifah Nur Hestiyani, S.Si., M.Biotech.
3. PIC 3 : Anriani Puspita Karunia Ning Widhi, S.Si., M.Si.
4. Administrasi : Meike Wihastuti, SE.
 3

JADWAL GLOBAL PROSES PEMBELAJARAN DAN TANGGAL PENTING

TEMA/TOPIK WAKTU
Kuliah 23 September-10 Oktober 2019
Tutorial Tutorial 1 Kamis, 26 September 2019 Pkl.10.00-11.50
Tutorial 2 Selasa, 1 Oktober 2019 Pkl.10.00-11.50
Tutorial 3 Kamis, 3 Oktober 2019 Pkl.10.00-11.50
Tutorial 4 Selasa, 8 Oktober 2019 Pkl.10.00-11.50
Tutorial 5 Kamis, 10 Oktober 2019, Pkl.10.00-11.50

Tutorial Etika Penelitian Jum’at, 11 Oktober 2019, pkl. 08.00-09.50

informed consent
Tutorial Critical Tutorial I Selasa, 15 Oktober 2019, pkl.10.00-11.40
Appraisal Review jurnal
strobe
Tutorial II Selasa, 15 Oktober 2019, pkl. 13.00-14.40
Review jurnal
consort dan
eksperimental
Diskusi kelasPengolahan Diskusi kelas I Gelombang I : Jum’at,11 Oktober 2019,
Data Input data pkl.10.00-11.50
Gelombang II : Jumat, 11 Oktober 2019,
pkl.13.00-14.50
Diskusi kelas II Gelombang I : Senin, 14 Oktober 2019,
Uji Hipotesis pkl.08.00-09.50
Gelombang II : Senin, 15 Oktober 2019,
pkl.10.00-11.50
CBT CBT 1 : Senin, 7 Oktober 2019
CBT 2 : Rabu, 16 Oktober 2019
Presentasi Proposal Kamis, 17 Oktober 2019
Remidi CBT Jum’at, 18 Oktober 2019
 4

MATRIKS KURIKULUM
No Topik Tujuan Pembelajaran Pengampu Metode Durasi
1 Hipotesis Penelitian 1. Mahasiswa mampu dr. Yudhi Kuliah 50
menjelaskan pengertian Wibowo, M.PH
hipotesis
2. Mahasiswa mampu menjelaskan
cirri hipotesis yang baik
3. Mahasiswa mampu menjelaskan
jenis-jenis hipotesis
2 Populasi dan Sampel 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pengertian dan karakteristik Wibowo, M.PH
populasi
2. Mahasiswa mampu menjelaskan
konsep sampel sebagai bagian
representatif dari populasi
3 Variabel dan Skala 1. Mahasiswa mampu menjelaskan Dr.dr. Lantip Kuliah 100
Penelitian pengertian dan jenis-jenis Rujito,
variabel M.Si.Med
2. Mahasiswa mampu menjelaskan
hubungan antar variabel
3. Mahasiswa mampu
menjelaskandefinisi operasional
variable
4. Mahasiswa mampu menjelaskan
jenis-jenis skala penelitian
beserta ciri-cirinya
4 Pengukuran Data dan 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
Instrumen Penelitian metode pengukuran data Roestijawati,
2. Mahasiswa mampu menjelaskan MKK
metode pengumpulan data
untuk kepentingan penelitian
3. Mahasiswa mampu menjelaskan
pemilihan instrumen penelitian
4. Mahasiswa mampu menjelaskan
prinsip penyusunan instrumen
penelitian
5. Mahasiswa mampu menjelaskan
uji validitas dan reliabilitas pada
instrument penelitian
5 Dasar-dasar 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
Biostatistika konsep dasar statistika Wibowo, M.PH
2. Mahasiswa mampu menjelaskan
manfaat biostatistika dalam
penelitian
3. Mahasiswa mampu penjelaskan
peran probabilitas dalam data
penelitian kesehatan
6 Statistik Deskriptif 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
berbagai teknik penyajian data Roestijawati,
baik data kualitatif maupun data MKK
kuantitatif
2. Mahasiswa mampu menjelaskan
penggunaan statistik untuk
mendeskripsikan atribut suatu
 5

kumpulan data dan menyusun

distribusi frekuensi
3. Mahasiswa mampu menghitung
ukuran kecenderungan sentral
(central tendency ratio) untuk
mendeskripsikan titik tengah
distribusi suatu pengukuran,
yaitu mean, median, dan modus
4. Mahasiswa mampu membuat
dan mendeskripsikan ukuran
penyebaran dan ukuran
pemusatan dalam bentuk tabel
dan grafik untuk variabel
numeric
7 Sampling dan 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
Estimasi berbagai teknik sampling Wibowo, M.PH
2. Mahasiswa mampu menjelaskan
perhitungan jumlah sampel
yang diperlukan pada populasi
3. Mahasiswa mampu menjelaskan
konsep convidence interval dan
interpretasinya
4. Mahasiswa mampu menjelaskan
perhitungan jumlah sampel
pada proporsi dan populasi
8 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan dr. Miko Kuliah 100
Kualitatif definisi penelitian kualitatif Ferine,
2. Mahasiswa mampu menjelaskan M.Med.Ed
metodologi penelitian kualitatif
9 Instrumen penelitian 1. Mahasiswa mampu menjelaskan Dyah Woro, Kuliah 50
kualitatif mengenai instrument penelitian M.Psi
kualitatif
10 Pengolahan dan 1. Mahasiswa mampu menjelaskan Dyah Woro, Kuliah 100
Penyajian Data proses pengolahan dan M.Psi
Kualitatif penyajian data pada penelitian
kualitatif
11 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr. Eman Kuliah 100
Kuantitatif definisi penelitian kuantitatif Sutrisna.,
2. Mahasiswa mampu menjelaskan M.Kes
jenis-jenis penelitian kuantitatif
beserta cirinya
12 Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
Epidemiologi definisi penelitian epidemiologi Roestijawati,
Observasional observasional MKK
2. Mahasiswa mampu menjelaskan
jenis-jenis penelitian
epidemiologi observasional
3. Mahasiswa mampu menjelaskan
penggunaan penelitian
epidemiologi observasional
13 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr.Dody Kuliah 100
Eksperimental definisi penelitian Novrial, SpPA.,
Laboratoris eksperimental laboratoris M.Si.Med
2. Mahasiswa mampu menjelaskan
 6

penelitian dengan hewan coba

3. Mahasiswa mampu menjelaskan
teknik handling hewan coba
yang benar
4. Mahasiswa mampu menjelaskan
penelitian in vitro
14 Rancangan Penelitian 1. Mahasiswa mampu menjelaskan Dr.dr. Wahyu Kuliah 100
Eksperimental definisi penelitian eksperimental Siswandari,
Dengan Subyek dengan subyek manusia Sp.PK.,
Manusia 2. Mahasiswa mampu menjelaskan M.Si.Med
penelitian quasi eksperimental
3. Mahasiswa mampu menjelaskan
uji klinis
15 Pengolahan Data 1. Mahasiswa mampu menjelaskan Dr.dr. Lantip Kuliah 100
tahap-tahap pengolahan data Rujito, M.Si.
2. Mahasiswa mampu menjelaskan Med Praktikum 100
cara penyajian data
3. Mahasiswa mampu melakukan
pengolahan data untuk
kepentingan uji statistika
16 Uji Hipotesis 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
definisi uji hipotesis Wibowo, M.PH
2. Mahasiswa mampu menjelaskan
tahap-tahap uji hipotesis
3. Mahasiswa mampu menjelaskan
pemilihan uji statistik
4. Mahasiswa mampu menjelaskan
nilai α (type II error) dan nilai β
(power) dalam uji hipotesis
17 StatisikParametrik 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
dan Non Parametrik definisi statistik parametrik dan Roestijawati,
non parametrik MKK
2. Mahasiswa mampu menjelaskan
perbedaan uji statistik
parametrik dan non parametric
18 Uji Beda Pada 2 1. Mahasiswa mampu menjelaskan dr. Khusnul Kuliah 100
Kelompok pemilihan uji beda antara 2 Muflikhah,
kelompok (uji t, Mann-Whitney, M.Sc
Wilcoxon)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji beda antara
2 kelompok

19 Uji Beda Antara 3 1. Mahasiswa mampu menjelaskan dr. Alfi Kuliah 100
Kelompok atau Lebih pemilihan uji beda antara 3 Muntafiah,
kelompok (ANOVA, ANCOVA, M.Sc
Kruskal-Wallis)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji beda antara
3 kelompok atau lebih
3. Mahasiswa mampu menjelaskan
pemilihan uji post hoc beserta
interpretasinya
 7

20 Analisis 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100

Multivariabel dasar pemilihan analisis Wibowo, M.PH
multivariabel
2. Mahasiswa mampu memilih uji
statistik multivariabel yang
tepat (regresi logistik, regresi
linier berganda, korelasi
berganda)
3. Mahasiswa mampu menjelaskan
interpretasi dari uji statistik
multivariable
21 Uji Regresi 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pemilihan uji regresi (linier Wibowo, M.PH
sederhana, berganda, logistik)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji regresi
22 Uji Korelasi 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pemilihan uji korelasi (Pearson, Wibowo, M.PH
Spearman, berganda, koefisien
kontingensi)
2. Mahasiswa mampu menjelaskan
interpretasi dari uji korelasi
3. Mahasiswa mampu menjelaskan
kekuatan hubungan
berdasarkan uji korelasi
23 Uji Asosiasi 1. Mahasiswa mampu menjelaskan dr. Yudhi Kuliah 100
pemilihan uji asosiasi (Chi Wibowo, M.PH
Square, Fisher, McNemar)
2. Mahasiswa mampu menjelaskan
interpretasi interpretasi dari uji
asosiasi
3. Mahasiswa mampu menjelaskan
Odds Ratio dan Relative Risk
24 Analisis Kualitatif 1. Mahasiswa mampu menjelaskan RR.Dyah Woro, Kuliah 100
teknik analisis kualitatif M.A
2. Mahasiswa mampu menjelaskan
kesimpulan / interpretasi teknik
analisis kualitatif
25 Etika Penelitian 1. Mahasiswa mampu menjelaskan dr. Miko Kuliah 100
konsep dasar etika penelitian Ferine,
2. Mahasiswa mampu menjelaskan M.Med.Ed Praktikum 100
regulasi tentang etik penelitian
pada hewan dan manusia
3. Mahasiswa mampu menjelaskan
hal-hal yang potensial menjadi
isu etik dalam penelitian
4. Mahasiswa mampu melakukan
simulasi informed consent
penelitian
26 Teknik Penulisan 1. Mahasiswa mampu menjelaskan dr.Vitasari Kuliah 100
Proposal Penelitian, perbedaan antara penulisan Indriani,MM, Praktikum 500
Laporan Penelitian, usul penelitian dan laporan Sp.PK,MSi.Me Penyusunan
Jurnal Ilmiah, dan penelitian d Proposal
Poster Ilmiah 2. Mahasiswa mampu menjelaskan
 8

teknik penulisan laporan

penelitian sesuai kaidah umum
3. Mahasiswa mampu menjelaskan
teknik jurnal dan artikel ilmiah
sesuai kaidah umum
4. Mahasiswa mampu menjelaskan
teknik penyusunan poster ilmiah
27 Telaah Jurnal Ilmiah 1. Mahasiswa mampu menjelaskan Dr.dr. Nendyah Kuliah 100
dan Critical teknik telaah jurnal ilmiah Roestijawati, Praktikum 100
Appraisal 2. Mahasiswa mampu memakai MKK
CONSORT dan STROBE dalam
kritisi jurnal.
3. Mahasiswa mampu
menjelaskan cara melakukan
critical appraisal pada suatu
jurnal ilmiah

METODE PEMBELAJARAN

I. KNOWLEDGE/KOGNITIF
1.A. KULIAH
Kuliah pendahuluan merupakan metode pemberian materi yang berkaitan dengan
kompetensi yang diinginkan dalam blok MRP dengan cara ceramah dan diskusi di kelas.
Kuliah ini diharapkan dapat memberikan bekal kepada mahasiswa untuk menguasai
konsep dasar yang dibutuhkan dalam mencapai kompetensi yang telah ditetapkan. Kuliah
diberikan oleh dosen atau narasumber yang ahli dalam bidangnya. Pada kuliah ini,
narasumber hanya memberikan garis besar materi saja, pendalaman materi oleh mahaiswa
dilakukan melalui metode pembelajaran yang lain seperti praktikum dan belajar mandiri.
Diharapkan dalam memberikan kuliah dosen atau narasumber dapat memacu peran aktif
mahasiswa.

1.B. TUTORIAL PENYUSUNAN PROPOSAL PENELITIAN

Mahasiswa dibagi menjadi kelompok-kelompok kecil dan didampingi oleh seorang
tutor. Tutor berperan sebagai pembimbing dalam penyusunan proposal penelitian yang
sudah ditulis oleh mahasiswa. Setiap mahasiswa wajib menulis bagian atau sub bab
proposal penelitian sesuai dengan jadwal yang sudah ditentukan. Pedoman penulisan
proposal penelitian mengacu pada Buku Panduan Skripsi dari Tim Komisi Tugas Akhir
FK Unsoed Jurusan Kedokteran Umum tahun 2018. Tutorial merupakan waktu untuk
mendapatkan bimbingan dari tutor dan masukan dari teman sekelompoknya. Saat
 9

melakukan bimbingan, mahasiswa mempresentasikan hasil tulisannya di depan tutor dan

teman kelompoknya selama kurang lebih 7 menit setiap mahasiswa. Mahasiswa
memberikan hardcopy hasil tulisannya kepada tutor saat bimbingan akan dimulai.
Mahasiswa disarankan memiliki buku log untuk mendokumentasikan setiap masukan atau
hal-hal penting selama proses bimbingan penulisan proposal penelitian. Proposal
penelitian dikumpulkan kepada admin pada akhir blok sesuai waktu yang ditentukan oleh
pengelola blok. Proposal penelitian dipresentasikan pada jadwal SOCA di akhir blok
dalam waktu 10 menit dengan ketentuan maksimal 10 slide yang berisi Bab 1, Bab 2 dan
Bab 3, dilanjutkan dengan feed back dari penguji selama lima menit.
 10

II. SKILLS/KETRAMPILAN
LATIHAN PENGOLAHAN DATA
Latihan pengolahan data merupakan latihan yang dilakukan di laboratorium komputer
dengan tujuan agar mahasiswa dapat melakukan pengolahan data yang diperoleh pada saat
melakukan penelitian. Latihan dipandu oleh staf dosen dan petugas laboratoium komputer
jurusan kedokteran FK Unsoed dan bersifat individual. Masing-masing mahasiswa melakukan
latihan pengolahan data sebanyak dua kali.
TUTORIAL ETIKA PENELITIAN
Tutorial Etika penelitian merupakan tutorial yang dilakukan di kelompok kecil dengan
tujuan agar mahasiswa dapat membuat dan mempraktikkan cara pengambilan informed
consent penelitian. Pada tutorial ini, mahasiswa membuat informed consent dan berpraktik
cara-cara pengambilan informed consent. Informed consent dibuat di rumah, kemudian
didiskusikan dan dipraktikkan dengan teman sekelompoknya, dengan dipandu oleh tutor.
TUTORIAL CRITICAL APPRAISAL
Tutorial critical appraisal merupakan praktikum yang dilakukan di kelompok kecil
dengan tujuan agar mahasiswa dapat menilai secara kritis kesahihan dan kemamputerapan
informasi jurnal. Setiap kelompok akan mendapatkan jurnal untuk dilakukan critical appraisal
menggunakan ―CONSORT dan atau STROBE Statement‖. Tiap kelompok melakukan critical
appraisal sebelum pelaksanaan tutorial dan dibahas pada saat praktikum bersama tutor.
EVALUASI PROSES PEMBELAJARAN

Evaluasi proses pembelajaran dilakukan oleh mahasiswa terhadap dosen, materi kuliah,
tutorial, praktikum dan ujian dalam bentuk kuesioner. Evaluasi diisi oleh setiap mahasiswa
pada akhir blok.

EVALUASI HASIL BELAJAR

Nilai akhir blok MRP ditentukan dengan kriteria sebagai berikut:

JENIS EVALUASI BOBOT NILAI

Ujian Tulis (CBT) 65%
Presentasi Proposal Penelitian 10%
Proposal Penelitian 25%
TOTAL 100%
 11

DAFTAR TUTOR
No Nama No. Telp email
1 dr. Afifah, M.Sc. 082242637171 afifah2403@gmail.com
Dr. dr. Dody Novrial, SpPA, 082328754870 dnovrial@gmail.com
2
MSi.Med.
3 dr. Hajid Rahmadianto M.,SpU 081703552448 hajidrahmadianto@gmail.com
081215003209 dzikrarana@gmail.com
4 Dr. dr. Dwi Utami Anjarwati, M.Kes. atau
dzikrarana@yahoo.com
5 dr. Ika Murti Harini, M.Sc. 08156988853 murti_cool@yahoo.com
6 Dr. dr. Tutik Ida Rosanti, M.Kes 08112600255 tutikidarosanti@yahoo.com
dr. Vitasari Indriani, MM., M.Si.Med, 081226717938 vita.indriani@gmail.com
7
Sp.PK.
8 dr. Khusnul Muflikhah, MSc. 08179403457 khusnulmuflikhah@yahoo.com
9 Dr. dr. Lantip Rujito, MSi.Med. 081548803168 rujitoku@yahoo.com
10 dr. Tri Okmawati Handini, M.Si. 081325456555 dinienugroho1980@gmail.com
11 Dr. dr. Eman Sutrisna, M.Kes. 081327695198 rahma24sutrisna@gmail.com
Dr. dr. Wahyu Siswandari, MSi.Med., 081215732017 wahyu_swdr@yahoo.com
12
SpPK.

Tutor Cadangan :
1.Dr dr. Alfi Muntafiah, MSc. 085865137470 alfimuntafiah99@gmail.com
2.dr. dr. Fajar Wahyu Pribadi, MSc. 08122841829 fajarwahyupribadi@yahoo.com
3. dr. Octavia Permata Sari, M.Sc 081328003790 octavia.murdani@gmail.com
4. dr. Miko Ferine, Med.Ed 08151685710 mikoferine@gmail.com
 12

DAFTAR KELOMPOK

KELOMPOK 1 dr. Afifah, M.Sc. KELOMPOK 2 Dr. dr. Dody Novrial, SpPA, MSi.Med. KELOMPOK 3 dr. Hajid Rahmadianto M.,SpU
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A017001 FAUZIAH RAHMA ISTIANINGRUM 1 G1A017002 UMMI SYAFIQAH 1 G1A017003 MOHAMMAD IQBAL RAMADHAN
2 G1A017014 AULIA OKHID ARIZA 2 G1A017015 ARIFATUL ULUMIYAH 2 G1A017016 NABILA RIZMI PRADINA
3 G1A017026 SARAH PARAMITA SASKYARASMI 3 G1A017027 NIDA HUMAIDA ZAHRA 3 G1A017028 SARAH AZAHRA ROSA IRAWAN
4 G1A017038 ANANDA SITI FATIMAH 4 G1A017039 INDIRA ANISYA MARCHITASARI 4 G1A017040 BRIGITA CHRISTI PETRA KARINA F
5 G1A017051 GESTY GITA ANGGRAENI 5 G1A017052 FAJRIYAN NALA ALVIN HUDAYA 5 G1A017053 ZAHRA MUTHMAINNAH KOMARA
6 G1A017063 RYANDA DAVITASARI 6 G1A017064 NALLA FATHIE CAMELLA 6 G1A017065 ABRAR MUKARRAM SETIAWAN
7 G1A017075 ISMI ROBIYATUL ADAWIYAH 7 G1A017076 DIZA FARA RAMADHANTI 7 G1A017077 RADYA PUTRA PRATAMA
8 G1A017088 AULIA SALSA BIELA 8 G1A017089 AULIA FIRDHA FATIKHARIZQI 8 G1A017090 FARAH NISRINA NAURAH
9 G1A017100 INDININTIAS WINURA P 9 G1A017101 ABDURRAHMAN SULTHAN AHMAD 9 G1A017102 MUHAMAD IQBAL BAIHAQI
10 G1A017112 ARDYA GALUH SEKAR NIRWANA 10 G1A017113 ROBBY AL FAUZI 10 G1A017114 LISTYANING ASTIKA SARI
11 G1A015069 SANG AJI SAMUDRA ANUGRAH 11 G1A015047 FATIMAH 11 G1A015022 NURHAYATI

Dr.dr.Dwi Utami Anjarwati,

dr. Ika Murti Harini, M.Sc. Dr. dr. Tutik Ida Rosanti, M.Kes
KELOMPOK 4 M.Kes. KELOMPOK 5 KELOMPOK 6
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A017004 DYAH LUSTIYANINGSIH 1 G1A017005 DIYAN AYU PERTIWI 1 G1A017006 NINDYA HERMA WIDHIANTI
2 G1A017017 ANNISA MARDIANTI SUKMARA 2 G1A017018 PUTRI PITALOKA 2 G1A017019 KHAFID NAWAWI
3 G1A017029 BAYU ARIANDI LUBIS 3 G1A017030 PUTRI ZULFIRA YASMIN 3 G1A017031 IRENE AYU PERMATA DEWI
4 G1A017041 PASKALIS BHASKARA UNGGUL Y 4 G1A017042 INDUWIDI QUAMILLA RENGGANI 4 G1A017043 FAHRUL ZHULMI
5 G1A017054 DENDY ARIEZAPUTRA 5 G1A017055 ALVIRA DWIGITA H 5 G1A017056 JOFIANDO
6 G1A017066 MAULIDYA CHILMA NABILA 6 G1A017067 FEBRIANI KHAIRUNISA FITRIASTUTI 6 G1A017068 IRA IMANIAH
7 G1A017078 CHALIMATUSSA`DIYAH 7 G1A017079 JOHANES HASIAN SIAHAAN 7 G1A017080 DIMO HARY ANGGARA
8 G1A017091 GHEA PUTRI SORAYA 8 G1A017092 QURROTA A'YUN FADHILAH 8 G1A017093 PUTRI NUR'AFNI SA'ADAH
9 G1A017103 TIARA JAYANTI PUTRI 9 G1A017104 PUTRI EKA SESARIANA 9 G1A017105 DANIA
10 G1A017115 FAHIRA AZIZA 10 G1A017116 HERCYA ISABELITA ROSALINA 10 G1A017117 ARIBAH MASCAHYA KUSUMA
11 G1A015084 WULAN RIZKY HAERUNISSA 11 G1A015103 TRIAN NUR ENDAH FAJRIN 11 G1A015104 AJENG RIDHA ZULAFA
 13

dr. Vitasari Indriani, MM., M.Si.Med,

dr. Khusnul Muflikhah, MSc. Dr. dr. Lantip Rujito, MSi.Med.
KELOMPOK 7 Sp.PK. KELOMPOK 8 KELOMPOK 9
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A017007 RYVALDA NATAMA SOALOON HRP 1 G1A017008 IRSYAD MAJID RAHMADIA 1 G1A017009 PRISCA TIFFANY ANDREANETTA
2 G1A017020 NUR ASRI AINUN BASYIRAH AS 2 G1A017021 YUSRINA NIKA AMALIA 2 G1A017022 DYAH HAPSARI
3 G1A017032 NAZAL KARIM AKBARI 3 G1A017033 AULIA NURY FAZA 3 G1A017034 DYAH ASRI HAYUNINGTYAS
4 G1A017044 LUQLUN SALISA SUGIARTO 4 G1A017045 ISTIQOMAH 4 G1A017046 ZAKIY PANDU PANGESTU
5 G1A017057 ANNISA SEKAR SALSABILA 5 G1A017058 ADELIA PUJI SURYANINGTIYAS 5 G1A017059 ALFRINA AMALIAH ALI
6 G1A017069 AMANAH SEKAR KINASIH 6 G1A017070 BHIMO SANTRI BAIHAQI 6 G1A017071 SAHDA VANIA SALSABIILA
7 G1A017082 ENDANG PURWATI 7 G1A017083 ARIF NUR AZIZ 7 G1A017084 CHAUSAR PUTRA BENAGIL
8 G1A017094 HIKMAH NUR AZIZAH 8 G1A017095 FATYA NABILA 8 G1A017096 ABIEL AMAZIA PUTRI
9 G1A017106 CLEVIRA MUTIARA ANJANI 9 G1A017107 REFISTHIA AYU ERWANDA PUTRI 9 G1A017108 NURUL SALMA YASYFI
10 G1A017118 ARSYTHA HARYOKO PUTRI 10 G1A014060 SAHRUL Z Z NUHUYANAN 10 G1A014072 LINTANG INGGAR SARI
11 G1A015105 ELMA WILIANDINI 11 G1A017107 REFISTHIA AYU ERWANDA PUTRI 11 G1A015109 DINDA WIGRHA APRILLINDA

Dr. dr. Wahyu Siswandari,

dr. Tri Okmawati Handini, M.Si. Dr. dr. Eman Sutrisna, M.Kes.
KELOMPOK 10 KELOMPOK 11 KELOMPOK 12 MSi.Med., SpPK.
NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA NO NIM NAMA MAHASISWA
1 G1A017010 RIZKY HANDAYANI 1 G1A017012 FENTY DWI EDVIANTI ISWAR 1 G1A017013 SABRINA DHIA SALSABILA
2 G1A017023 AINUR RAHMAT 2 G1A017024 IFFA KARIMAH 2 G1A017025 AHMAD FARIQ
3 G1A017035 SERINA WIDYASTUTI 3 G1A017036 TWYTA HAKIM WENING KALBU 3 G1A017037 FADILA PUTRI NOVITASARI
4 G1A017047 MEILINDA PRATIWI 4 G1A017049 MUHAMMAD SIDQI FAHMI 4 G1A017050 AQURISMA SIKAPISCA FITRI
5 G1A017060 ALYA FIQI NABILA 5 G1A017061 IRSE PRIYAGANDA BANI MUSA 5 G1A017062 CHAERUNNISA HIDAYAH
6 G1A017072 FIDDHANIE MURDHANA FATHIR 6 G1A017073 ARI MIRNA MADANI 6 G1A017074 OKTAVIA NUR ROHMAWATI
7 G1A017085 DITA AYU DEWI LARAS SATI 7 G1A017086 ANINDITA ADZANI 7 G1A017087 BELLA KHOIRUNISA PRIHANDINI
8 G1A017097 SALLAZARIA HANIN PRAMESWARI S.A 8 G1A017098 NANDA ARIFIN ARIF 8 G1A017099 AMELINDA RIFDAH AQIILAH
9 G1A017109 ELMO ALFIAN HIDAYAT 9 G1A017110 CATHLEYA EKLA SALSABILA 9 G1A017111 NOUVAL FIKRIE KEANDRE
10 G1A015008 AZHAR HAWARI MALAU 10 G1A015013 NANA NURDAHLIA M. 10 G1A015015 HOCIE TRINANDA SARDI
11 G1A015111 DIAN AYU FEBRIANTI 11 G1A015119 YUNDA HARYATI 11 G1A015120 YULIA NATALIA
12 G1A016064 NURAIDA ABSHARINA AWANIS
 14

JADWAL BLOK 5.2 TA. 2019/2020

JURUSAN KEDOKTERAN UMUUM FAKULTAS KEDOKTERAN UNIVERSITAS JENDRAL SOEDIRMAN
Ruang Kuliah di Gedung A lantai 2

MINGGU KE 1
WAKTU Senin Selasa Rabu Kamis Jumat
23 September 2019 24 September 2019 25 September 2019 26 September 2019 27 September 2019
07.00-07.50
10.Instrumen penelitian
Sosialisasi Pembelajaran kualitatif (Rr.Diyah Woro,
08.00-08.50 4. Variabel dan Skala 9.Rancangan Penelitian S.Psi, MA)
1.Teknik Penulisan Penelitian (DR.dr Lantip Rujito, Kualitatif (dr. Miko Ferine,
Proposal Penelitian (dr. Msi.Med) M.Med.Ed)
Vitasari Indriyani, 11.Pengolahan dan Penyajian
Sp.PK,MM.,Msi.Med) Data Kualitatif (Rr.Diyah
09.00-09.50
Woro, S.Psi, MA)
2.Hipotesis Penelitian (dr.
5.Pengukuran Data dan
10.00-10.50 Yudhi Wibowo, M.PH) 8.Sampling dan Estimasi (dr.
Instrumen Penelitian (Dr.dr. TUTORIAL 1
Yudhi Wibowo, M.PH)
Nendyah Roestijawati, MKK)
11.00-11.50 Istirahat
12.00-12.50 Istirahat Istirahat Istirahat Istirahat

13.00-13.50 3.Populasi dan Sampel (dr. 6.Dasar-dasar Biostatistika (dr. 7.Statistik Deskriptif (Dr.dr.
Skills Lab
Yudhi Wibowo, M.PH) Yudhi Wibowo, M.PH) Nendyah Roestijawati, MKK)
14.00-14.50
 15

MINGGU KE 2
WAKTU Senin Selasa Rabu Kamis Jumat
30 September 2019 01 Oktober 2019 02 Oktober 2019 03 Oktober 2019 04 Oktober 2019
07.00-07.50
08.00-08.50 15.Rancangan Penelitian
12.Rancangan Penelitian
Eksperimental Dengan Subyek 17.Uji Hipotesis (dr. Yudhi 19.Uji Beda Pada 2 Kelompok 21.Analisis Multivariabel (dr.
Kuantitatif (Dr.dr. Eman
Manusia (Dr.dr. Wahyu Wibowo, M.PH) (Khusnul Muflikhah, M.Sc) Yudhi Wibowo, M.PH)
Sutrisna., M.Kes)
Siswandari, Sp.PK., M.Si.Med)
09.00-09.50
22. Teknik Penulisan Laporan
13.Penelitian Epidemiologi Penelitian, Jurnal Ilmiah, dan
Observasional Poster Ilmiah (dr. Vitasari
10.00-10.50 TUTORIAL 2 TUTORIAL 3 Indriyani, Sp.PK,MM.,Msi.Med)
(Dr.dr.Nendyah
Roestijawati,MKK)
11.00-11.50
12.00-12.50 Istirahat Istirahat Istirahat Istirahat Istirahat
14.Rancangan Penelitian
20.Uji Beda Antara 3 18.Statisik Parametrik dan
13.00-13.50 Eksperimental Laboratoris 16.Pengolahan Data (Dr.dr.
Skills Lab Kelompok atau Lebih (dr. Alfi Non Parametrik (Dr.dr.
(Dr.dr.Dody Novrial, SpPA., Lantip Rujito, M.Si. Med)
Muntafiah, M.Sc ) Nendyah Roestijawati, MKK)
14.00-14.50 M.Si.Med)
 16

MINGGU KE 3
WAKTU Senin Selasa Rabu Kamis Jumat
07 Oktober 2019 08 Oktober 2019 09 Oktober 2019 10 Oktober 2019 11 Oktober 2019
07.00-07.50
27.Telaah Jurnal Ilmiah dan
08.00-08.50 23.Uji Korelasi (dr. Yudhi 25.Etika Penelitian (dr. Miko Tutorial Etika Penelitian
Critical Appraisal Dr.dr.
Wibowo, M.PH) Ferine, M.Med.Ed) (Kelompok kecil) (di R.PBL)
09.00-09.50 Nendyah Roestijawati, MKK )
CBT I (1-14) Diskusi kelas (lab.kom)
10.00-10.50 pengolahan data 1
26.Analisis Kualitatif (RR.Dyah
TUTORIAL 4 TUTORIAL 5 Input data ke SPSS
Woro, M.A)
Gelombang I
11.00-11.50 (dr. Afifah, M.Sc)
12.00-12.50 Istirahat Istirahat Istirahat Istirahat Istirahat
13.00-13.50 Diskusi kelas (lab. Kom)
pengolahan data 1
24.Uji Asosiasi (dr. Yudhi
Skills Lab Input data ke SPSS
Wibowo, M.PH)
Gelombang II
14.00-14.50 (dr. Afifah, M.Sc)
15.00-15.50
16.00-16.50
 17

MINGGU KE 4

WAKTU Senin Selasa Rabu Kamis Jumat

14 Oktober 2019 15 Oktober 2019 16 Oktober 2019 17 Oktober 2019 18 Oktober 2019
07.00-07.50
Diskusi kelas (lab. Kom)
08.00-08.50 Pengolahan Data 2
Uji Hipotesis: Uji T, Uji chi
square, ANOVA, Regresi
Gelombang I
09.00-09.50 (dr. Yudhi Wibowo, M.PH)
CBT II (15-27) REMIDI CBT
Diskusi kelas (lab. Kom)
10.00-10.50 Pengolahan Data 2
Uji Hipotesis: Uji T, Uji chi Tutorial Critical Appraisal 1
Presentasi Proposal
square, ANOVA, Regresi (kelompok kecil) (di R.PBL)
Gelombang II
11.00-11.50 (dr. Yudhi Wibowo, M.PH)
12.00-12.50 Istirahat Istirahat Istirahat Istirahat Istirahat

13.00-13.50 Pengumpulan Naskah Tutorial Critical Appraisal 2

Skills Lab
Proposal Penelitian (kelompok kecil) (di R.PBL)
14.00-14.50
 18

TEKNIS PELAKSANAAN KEGIATAN

1. KULIAH
- Kuliah dilaksanakan di ruang kuliah gedung A
- Admin blok mengingatkan dosen pengampu sehari sebelum perkuliahan.
- Mahasiswa datang 10 menit sebelum perkuliahan dimulai.
- Mahasiswa bersama caraka mengecek sound system dan LCD sebelum dosen datang
- Tiga puluh menit dosen tidak datang tanpa pemberitahuan, kuliah dianggap batal dan digantikan pada
jadwal yang lain.
2. TUTORIAL PENYUSUNAN PROPOSAL PENELITIAN
- Tutorial penyusunan proposal penelitian dilaksanakan di ruang PBL sesuai jadwal yang sudah
ditentukan.
- Mahasiswa perwakilan kelompok mengingatkan tutor sehari sebelum jadwal tutorial.
- Mahasiswa menyusun dan menulis proposal penelitian untuk dikonsultasikan dan dipresentasikan
pada saat tutorial. Ketentuan penyusunan proposal penelitian mengacu pada Buku Pedoman
Penyusunan Skripsi 2018, dengan pembagian:
 Tutorial 1 :BAB I. PENDAHULUAN
o Penelitian Observasional (Epidemiologis): Latar Belakang, Perumusan Masalah, Tujuan dan
Manfaat, Keaslian Penelitian
o Penelitian Eksperimental Laboratorium: Latar Belakang, Perumusan Masalah, Tujuan dan
Manfaat,
o Penelitian Kualitatif : Latar Belakang Penelitian, Tujuan Penelitian, Manfaat Penelitian,
Perbandingan dengan penelitian terdahulu.
 Tutorial 2 :BAB II. TINJAUAN PUSTAKA
o Penelitian Observasional (Epidemiologis): Materi Pustaka, Kerangka Pemikiran Penelitian,
Kerangka Konsep Penelitian, Hipotesis
o Penelitian Eksperimental Laboratorium: Materi Pustaka, Kerangka Pemikiran Penelitian,
Kerangka Konsep Penelitian, Hipotesis (bila ada)
o Penelitian Kualitatif : Kajian Pustaka, Kerangka Konsep Penelitian, Pertanyaan Penelitian
 Tutorial 3 :BAB III. METODE PENELITIAN
o Penelitian Observasional (Epidemiologis): Rancangan Penelitian, Populasi dan Sampel,
Variabel Penelitian, Definisi Operasional Variabel
o Penelitian Eksperimental Laboratorium: Materi dan Bahan, Metode Penelitian, Rancangan
Percobaan/metode pengambilan sampel sebagai bahan penelitian, Variabel yang diukur.
o Penelitian Kualitatif : Rancangan Penelitian, Informan Penelitian, Teknik Pengumpulan
Data
 Tutorial 4 : BAB III. METODE PENELITIAN
o Penelitian Observasional (Epidemiologis): Pengumpulan Data, Tata Urutan Kerja, Analisis
Data, Waktu dan Tempat Penelitian, Jadwal Penelitian)
o Penelitian Eksperimental Laboratorium: Cara Mengukur variabel, Tata urutan Kerja,
Analisis Data, Waktu dan Tempat, Jadwal Penelitian.
 19

o Penelitian Kualitatif : Prosedur Analisis dan Interpretasi Data, Kredibilitas Penelitian, Etika
Penelitian
 Tutorial 5 : Review BAB I-BAB III
 Tugas mahasiswa:
o Menulis proposal penelitian sesuai ketentuan jadwal pertemuan tutorial.
o Mengirim draf proposal penelitian dalam bentuk soft file ke email tutor kelompoknya H-1
jadwal pertemuan Tutorial
o Menyerahkan hardcopy proposal penelitian yang sudah dibuat sesuai jadwal pertemuan
tutorial.
o Mempresentasikan proposal penelitian dalam bentuk power point selama maksimal 7 menit,
dilanjutkan diskusi maskimal selama tiga menit untuk mendapatkan masukan dari tutor dan
teman sekelompoknya.
o Merevisi proposal penelitian sesuai masukan tutor dan teman kelompok.
o Di akhir tutorial ke-3 dan ke-4 mahasiswa diminta membuat satu resume mengenai desain
penelitian satu teman sekelompoknya (yang berbeda dengan desainnya). Format resume
bebas, ditulis tangan, dikumpulkan ke sekretariat blok maksimal 24 jam setelah selesai
tutorial.
o Memberi masukan terhadap proposal penelitian teman kelompoknya.
 Tugas tutor:
o Mendengarkan dan mencermati pemaparan proposal penelitian oleh setiap mahasiswa.
o Memberikan arahan, koreksi, dan masukan terhadap proposal penelitian yang telah dibuat
oleh mahasiswa.
3. DISKUSI KELAS PENGOLAHAN DATA
- Diskusi kelas dilaksanakan di Laboratorium Komputer.
- Diskusi kelas dilaksanakan 2 kali pertemuan.
a. Pertemuan 1: Pengolahan data (input data ke SPSS)
b. Pertemuan 2 : Analisis data (Uji Hipotesis: Uji T, Uji chi square, ANOVA, Regresi)
- Mahasiswa membaca referensi latihan Pengolahan Data (Pengantar Satistika Kedokteran, M.Sopiyudin
Dahlan)
4. TUTORIAL INFORMED CONSENT (TUTORIAL ETIKA PENELITIAN)
Tutorial ini dilaksanakan satu kali. Mahasiswa membuat informed consent di rumah, kemudian
direview bersama dengan teman sekelompok dan sekaligus dipraktekkan pada saat praktikum (dipandu
oleh tutor). Mahasiswa membuat informed consent sesuai topik proposal penelitian yang telah dibuat. Jika
proposal penelitiannya tidak memerlukan informed consent, maka mahasiswa membuat informed consent
dari penelitian yang lain, yaitu jurnal atau skripsi (topik proposal penelitian tiap mahasiswa tidak boleh
sama). Format informed consent dapat diunduh di web kepk Fk Unsoed: http://fk.unsoed.ac.id/komisi-etik-
penelitian-kesehatan-fakultas-kedokteran-universitas-jenderal-soedirman/
- Tugas mahasiswa:
o Membuat informed consent di rumah
 20

o Mereview dan mendiskusikan informed consent dengan tutor dan teman kelompoknya
(berpasangan)
o Berpraktik cara menyampaikan informed consent kepada orang awam pada saat praktikum
(berpasangan).
- Tugas tutor:
o Memberi masukan terhadap informed consent yang dibuat oleh mahasiswa.
o Memberi masukan terhadap praktik mahasiswa dalam menyampaikan informed consent
kepada orang awam.
5. TUTORIAL CRITICAL APPRAISAL
- Tutorial dilaksanakan di ruang PBL
- Tutorial dipandu oleh seorang tutor.
- Mahasiswa mengerjakan appraisal sebelum tutorial dilaksanakan dan dikumpulkan serta dibahas pada
saat praktikum.
- Pada tutorial critical appraisal 1, dilakukan menggunakan STROBE statement terhadap jurnal yang
sudah ditentukan.
- Tutorial critical appraisal 2, dilakukan menggunakan CONSORT statement dan kualitatif terhadap
jurnal yang sudah ditentukan.
- Tugas Mahasiswa:
o Masing-masing mahasiswa melakukan critical appraisal di rumah.
o Mencetak dan membawanya saat praktikum.
o Mendiskusikan dengan tutor dan teman kelompoknya.
- Tugas Tutor:
o Membahas dan mendiskusikan critical appraisal bersama mahasiswa terhadap jurnal yang
sudah disediakan.
6. Ujian Tulis Komprehensif
- Ujian tulis komprehensif (UTK) dilaksanakan sesuai jadwal yang telah ditetapkan.
- Bentuk soal UTK adalah Multiple Choice Question dengan satu pilihan jawaban benar yang
dilaksanakan dengan Computer Based Test.
7. Presentasi Proposal Penelitian
- Presentasi proposal penelitian dilaksanakan di ruang PBL.
- Setiap mahasiswa membuat presentasi dalam bentuk power point maksimal 10 slide yang berisi Bab 1-
3.
- Waktu presentasi adalah 7 menit dan tanya jawab 5 menit.
- Mahasiswa dipanggil satu-persatu untuk presentasi.
- Mahasiswa yang tidak sedang presentasi berada di ruang karantina.
- Penilaian oleh seorang penguji meliputi sikap, penyajian, kemampuan mengemukakan pendapat,
penguasaan materi.
8. Naskah Proposal Penelitian
- Naskah proposal penelitian diserahkan admin blok pada hari Senin, 14 Oktober 2019, maksimal pukul
14.50.
 21

- Naskah proposal penelitian akan diberikan kepada penguji 2 hari sebelum presentasi proposal
penelitian.
- Penguji memberikan penilaian terhadap proposal penelitian dan lembar hasil penilaian diserahkan
kepada admin blok paling lambat setelah presentasi proposal penelitian.
- Penilaian naskah proposal penelitian sesuai dengan ketentuan Buku Pedoman Penyusunan Skripsi
Tahun 2018.

LAMPIRAN
1. STROBE dan CONSORT
2. Lembar penilaian presentasi proposal penelitian
3. Lembar penilaian naskah proposal penelitian.
4. Buku Panduan Penulisan SKRIPSI 2018
5. Daftar jurnal untuk critical appraisal (dicetak terpisah)
6. Ceklist telaah jurnal eksperimental dan kualitatif
 22

STROBE Statement—Checklist of items that should be included in reports of cross-sectional studies

Item
No Recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done
and what was found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment,
exposure, follow-up, and data collection
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of
Participants
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect
modifiers. Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of
Measurement assessment (measurement). Describe comparability of assessment methods if there is
more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable,
describe which groupings were chosen and why
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) If applicable, describe analytical methods taking account of sampling strategy
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially
eligible, examined for eligibility, confirmed eligible, included in the study,
completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and
information on exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
Outcome data 15* Report numbers of outcome events or summary measures
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and
their precision (eg, 95% confidence interval). Make clear which confounders were
adjusted for and why they were included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a
meaningful time period
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and
sensitivity analyses
 23

Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or
imprecision. Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations,
multiplicity of analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if
applicable, for the original study on which the present article is based

*Give information separately for exposed and unexposed groups.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is
available at www.strobe-statement.org.
 24

STROBE Statement—Checklist of items that should be included in reports of cohort studies

Item
No Recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done
and what was found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment,
exposure, follow-up, and data collection
Participants 6 (a) Give the eligibility criteria, and the sources and methods of selection of
participants. Describe methods of follow-up
(b) For matched studies, give matching criteria and number of exposed and
Unexposed
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect
modifiers. Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of
Measurement assessment (measurement). Describe comparability of assessment methods if there is
more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable,
describe which groupings were chosen and why
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) If applicable, explain how loss to follow-up was addressed
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially
eligible, examined for eligibility, confirmed eligible, included in the study,
completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and
information on exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
(c) Summarise follow-up time (eg, average and total amount)
Outcome data 15* Report numbers of outcome events or summary measures over time
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and
their precision (eg, 95% confidence interval). Make clear which confounders were
adjusted for and why they were included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a
meaningful time period
 25

Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and
sensitivity analyses
Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or
imprecision. Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations,
multiplicity of analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if
applicable, for the original study on which the present article is based

*Give information separately for exposed and unexposed groups.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is
available at http://www.strobe-statement.org.
 26

STROBE Statement—Checklist of items that should be included in reports of case-control studies

Item
No Recommendation
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done
and what was found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment,
exposure, follow-up, and data collection
Participants 6 (a) Give the eligibility criteria, and the sources and methods of case ascertainment
and control selection. Give the rationale for the choice of cases and controls
(b) For matched studies, give matching criteria and the number of controls per case
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect
modifiers. Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of
measurement assessment (measurement). Describe comparability of assessment methods if there is
more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable,
describe which groupings were chosen and why
Statistical methods 12 (a) Describe all statistical methods, including those used to control for confounding
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) If applicable, explain how matching of cases and controls was addressed
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially
eligible, examined for eligibility, confirmed eligible, included in the study,
completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and
information on exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
Outcome data 15* Report numbers in each exposure category, or summary measures of exposure
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and
their precision (eg, 95% confidence interval). Make clear which confounders were
adjusted for and why they were included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a
meaningful time period

1
 27

Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses

Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision.
Discuss both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity
of analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable,
for the original study on which the present article is based

*Give information separately for cases and controls.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available
at http://www.strobe-statement.org.
 28

STROBE Statement—checklist of items that should be included in reports of observational studies

Item Page Relevant text from

No. Recommendation No. manuscript
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or the abstract
(b) Provide in the abstract an informative and balanced summary of what was done and what was
Found
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Objectives 3 State specific objectives, including any prespecified hypotheses
Methods
Study design 4 Present key elements of study design early in the paper
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, exposure,
follow-up, and data collection
Participants 6 (a) Cohort study—Give the eligibility criteria, and the sources and methods of selection of
participants. Describe methods of follow-up
Case-control study—Give the eligibility criteria, and the sources and methods of case
ascertainment and control selection. Give the rationale for the choice of cases and controls
Cross-sectional study—Give the eligibility criteria, and the sources and methods of selection of
Participants
(b) Cohort study—For matched studies, give matching criteria and number of exposed and
Unexposed
Case-control study—For matched studies, give matching criteria and the number of controls per
Case
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect modifiers.
Give diagnostic criteria, if applicable
Data sources/ 8* For each variable of interest, give sources of data and details of methods of assessment
measurement (measurement). Describe comparability of assessment methods if there is more than one group
Bias 9 Describe any efforts to address potential sources of bias
Study size 10 Explain how the study size was arrived at
Continued on next page

1
 29

Quantitative 11 Explain how quantitative variables were handled in the analyses. If applicable, describe which
variables groupings were chosen and why
Statistical 12 (a) Describe all statistical methods, including those used to control for confounding
methods (b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed
(d) Cohort study—If applicable, explain how loss to follow-up was addressed
Case-control study—If applicable, explain how matching of cases and controls was addressed
Cross-sectional study—If applicable, describe analytical methods taking account of sampling
Strategy
(e) Describe any sensitivity analyses
Results
Participants 13* (a) Report numbers of individuals at each stage of study—eg numbers potentially eligible, examined
for eligibility, confirmed eligible, included in the study, completing follow-up, and analysed
(b) Give reasons for non-participation at each stage
(c) Consider use of a flow diagram
Descriptive data 14* (a) Give characteristics of study participants (eg demographic, clinical, social) and information on
exposures and potential confounders
(b) Indicate number of participants with missing data for each variable of interest
(c) Cohort study—Summarise follow-up time (eg, average and total amount)
Outcome data 15* Cohort study—Report numbers of outcome events or summary measures over time
Case-control study—Report numbers in each exposure category, or summary measures of exposure
Cross-sectional study—Report numbers of outcome events or summary measures
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and their precision
(eg, 95% confidence interval). Make clear which confounders were adjusted for and why they were
Included
(b) Report category boundaries when continuous variables were categorized
(c) If relevant, consider translating estimates of relative risk into absolute risk for a meaningful time
period
Continued on next page

2
 30

Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and sensitivity analyses
Discussion
Key results 18 Summarise key results with reference to study objectives
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or imprecision. Discuss
both direction and magnitude of any potential bias
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, multiplicity of
analyses, results from similar studies, and other relevant evidence
Generalisability 21 Discuss the generalisability (external validity) of the study results
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if applicable, for the
original study on which the present article is based

*Give information separately for cases and controls in case-control studies and, if applicable, for exposed and unexposed groups in cohort and cross-sectional studies.

Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and published examples of transparent reporting. The
STROBE checklist is best used in conjunction with this article (freely available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine
at http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is available at www.strobe-statement.org.
 31

CONSORT 2010 checklist of information to include when reporting a randomised trial*

Item Reported
Section/Topic No Checklist item on page No
Title and abstract
1a Identification as a randomised trial in the title
1b Structured summary of trial design, methods, results, and conclusions (for specific guidance see CONSORT for abstracts)
Introduction
Background and 2a Scientific background and explanation of rationale
objectives 2b Specific objectives or hypotheses

Methods
Trial design 3a Description of trial design (such as parallel, factorial) including allocation ratio
3b Important changes to methods after trial commencement (such as eligibility criteria), with reasons
Participants 4a Eligibility criteria for participants
4b Settings and locations where the data were collected
Interventions 5 The interventions for each group with sufficient details to allow replication, including how and when they were
actually administered
Outcomes 6a Completely defined pre-specified primary and secondary outcome measures, including how and when they
were assessed
6b Any changes to trial outcomes after the trial commenced, with reasons
Sample size 7a How sample size was determined
7b When applicable, explanation of any interim analyses and stopping guidelines
Randomisation:
Sequence 8a Method used to generate the random allocation sequence
generation 8b Type of randomisation; details of any restriction (such as blocking and block size)
Allocation 9 Mechanism used to implement the random allocation sequence (such as sequentially numbered containers),
concealment describing any steps taken to conceal the sequence until interventions were assigned
mechanism
Implementation 10 Who generated the random allocation sequence, who enrolled participants, and who assigned participants to
Interventions
Blinding 11a If done, who was blinded after assignment to interventions (for example, participants, care providers, those

CONSORT 2010 checklist Page 1

 32

assessing outcomes) and how

11b If relevant, description of the similarity of interventions
Statistical methods 12a Statistical methods used to compare groups for primary and secondary outcomes
12b Methods for additional analyses, such as subgroup analyses and adjusted analyses
Results
Participant flow (a 13a For each group, the numbers of participants who were randomly assigned, received intended treatment, and
diagram is strongly were analysed for the primary outcome
recommended) 13b For each group, losses and exclusions after randomisation, together with reasons
Recruitment 14a Dates defining the periods of recruitment and follow-up
14b Why the trial ended or was stopped
Baseline data 15 A table showing baseline demographic and clinical characteristics for each group
Numbers analysed 16 For each group, number of participants (denominator) included in each analysis and whether the analysis was
by original assigned groups
Outcomes and 17a For each primary and secondary outcome, results for each group, and the estimated effect size and its
estimation precision (such as 95% confidence interval)
17b For binary outcomes, presentation of both absolute and relative effect sizes is recommended
Ancillary analyses 18 Results of any other analyses performed, including subgroup analyses and adjusted analyses, distinguishing
pre-specified from exploratory
Harms 19 All important harms or unintended effects in each group (for specific guidance see CONSORT for harms)
Discussion
Limitations 20 Trial limitations, addressing sources of potential bias, imprecision, and, if relevant, multiplicity of analyses
Generalisability 21 Generalisability (external validity, applicability) of the trial findings
Interpretation 22 Interpretation consistent with results, balancing benefits and harms, and considering other relevant evidence
Other information
Registration 23 Registration number and name of trial registry
Protocol 24 Where the full trial protocol can be accessed, if available
Funding 25 Sources of funding and other support (such as supply of drugs), role of funders

*We strongly recommend reading this statement in conjunction with the CONSORT 2010 Explanation and Elaboration for important clarifications on all the items. If relevant, we also
recommend reading CONSORT extensions for cluster randomised trials, non-inferiority and equivalence trials, non-pharmacological treatments, herbal interventions, and pragmatic
trials. Additional extensions are forthcoming: for those and for up to date references relevant to this checklist, see www.consort-statement.org.

CONSORT 2010 checklist

 33

Lampiran 16. Formulir penilaian seminar proposal (form-09A)

FORM-09a

KEMENTERIAN RISET, TEKNOLOGI, DAN PENDIDIKAN TINGGI

UNIVERSITAS JENDERAL SOEDIRMAN
FAKULTAS KEDOKTERAN
Jalan Dr. Gumbreg Nomor 1 Berkoh Purwokerto 53146 Telepon (0281) 622022
Laman: http://fk.unsoed.ac.id E-mail: psi.fk@unsoed.ac.id

DAFTAR NILAI SEMINAR USUL SKRIPSI

Nama : __________________________________________________
NIM : __________________________________________________
Semester : __________________________________________________

Nilai
No Mata Uji / Penilaian Keterangan
Angka Huruf
1 Sikap
2 Penyajian
Kemampuan Mengemukakan
3
Pendapat
4 Penguasaan Materi
Jumlah
Rata - Rata

Purwokerto, __________________
Dosen Penilai,

________________________
NIP.
Nilai :
A = > 80
B = 66 – 79.9
C = 56 – 65.9
D = < 46
 34

Lampiran 17. Formulir penilaian seminar proposal (form-09B)

FORM-09a

KEMENTERIAN RISET, TEKNOLOGI, DAN PENDIDIKAN TINGGI

UNIVERSITAS JENDERAL SOEDIRMAN
FAKULTAS KEDOKTERAN
Jalan Dr. Gumbreg Nomor 1 Berkoh Purwokerto 53146 Telepon (0281) 622022
Laman: http://fk.unsoed.ac.id E-mail: psi.fk@unsoed.ac.id

DAFTAR NILAI SEMINAR USUL SKRIPSI

Nama : __________________________________________________
NIM : __________________________________________________
Semester : __________________________________________________

Nilai
No Mata Uji / Penilaian Keterangan
Angka Huruf
1 Sikap
2 Penyajian

3 Format Penulisan

4 Tata tulis dan Bahasa

Jumlah
Rata - Rata

Purwokerto, __________________
Dosen Penilai,

________________________
NIP.
Nilai :
A = > 80
B = 66 – 79.9
C = 56 – 65.9
D = < 46
 35

Lampiran 18. Formulir penilaian usul skripsi (Form-11)

FORM-11
LEMBAR PENILAIAN USUL SKRIPSI
JURUSAN KEDOKTERAN
FAKULTAS KEDOKTERAN
UNIVERSITAS JENDERAL SOEDIRMAN

Nama :
NIM :
JUDUL :
PEMBIMBING I :
PEMBIMBING II :
PENGUJI :

No Topik Bobot Nilai Bobot

x Nilai
1 Judul 10% 0-100
Mencerminkan isi/ masalah penelitian dengan jelas dan
menggunakan kalimat lengkap, efektif/ padat sesuai kaidah
Bahasa Indonesia yang baik dan benar
2 Pendahuluan 30% 0-100
Didasari dari latar belakang secara umum menuju ke suatu
pertanyaan penelitian atau hipotesis dan disusun berdasarkan
fakta-fakta dan informasi yang mendorong atau alasan
pentingnya dilakukan penelitian yang disusun secara
sistematis, logis dan ringkas.
Tujuan dan manfaat penelitian diuraikan secara jelas dan
nyata dan relevansinya dengan masalah yang hendak
dipecahkan
3 Tinjauan Pustaka 30% 0-100
Kerangka teori dan kerangka konsep
Referensi relevan sebagai dasar menjawab sementara sumber
permasalahan
Sumber pustaka minimal 50% berupa jurnal dilengkapi
dengan buku teks, kamus, dll
Hipotesis dirumuskan secara sederhana, jelas, padat, dapat
diuji dan dinyatakan dalam kalimat deklaratif
4 Metode Penelitian 30% 0-100
Materi dan Bahan (populasi dan sampel) : Sasaran/ materi
dan bahan yang akan digunakan dalam penelitian, termasuk
metode pengambilan sampel untuk penelitian non
eksperimental
Ketepatan metode penelitian yang digunakan (eksperimental
atau non eksperimental), dijabarkan secara rinci termasuk
langkah-langkah penelitian
Batasan operasional variable yang diukur dijelaskan secara
 36

tegas serta alat dan cara pengukurannya (validitas dan

reliabilitasnya)
Metode statistik yang digunakan untuk analisis data sesuai
dengan rancangan penelitiannya
TOTAL
Purwokerto………………
Penguji,

(…………………………….)

NIP………………………….
 37

Judul Jurnal untuk Tutorial Critical Appraisal 1

Kelompok 1 & 7 Fatty acid biomarkers of dairy fat consumption and incidence of
type 2 diabetes: A pooled analysis of prospective cohort studies
Kelompok 2 & 8 Prevalence and Associated Risk Factors of Falls among Rural
Community-Dwelling Older People: A Cross-Sectional Study
from Southern Sri Lanka
Kelompok 3 & 9 A case-control study into risk factors for acute hepatitis E in the
Netherlands, 2015–2017
Kelompok 4 & 10 Depression, emotional eating and longterm weight changes: a
population-based prospective study
Kelompok 5 & 11 Prevalence of vaping and smoking among adolescents in Canada,
England, and the United States: repeat national cross sectional
surveys
Kelompok 6 & 12 Risk factors associated with the recent cholera outbreak in Yemen:
a case-control study

Judul Jurnal untuk Tutorial Critical Appraisal 2

Kelompok 1-3 Anti-inflammatory and angiogenic effects of exercise training
in cardiac muscle of diabetic mice
Kelompok 4-6 Nanoparticles of zinc oxide defeat chlorpyrifos-induced
immunotoxic effects and histopathological alterations
Kelompok 7-9 Physical activity during pregnancy and its influence on delivery
time: a randomized clinical trial
Kelompok 10-12 Vaccine hesitancy: An overview on parents' opinions about
vaccination and possible reasons of vaccine refusal